Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-16

FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved a supplemental application for buprenorphine hydrochloride from Advagen Pharma Ltd, representing an approved amendment to an existing product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine Hydrochloride (Buprenorphine hydrochloride)

Snippet

SUPPL AP for BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE)